• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

COVID-19: Ophthalmic ASC Reopening Checklist released

Article

Guidance from the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, and the Outpatient Ophthalmic Surgery Society for reopening ambulatory surgery centers. 

The American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, and the Outpatient Ophthalmic Surgery Society have come together to release an Ophthalmic ASC Reopening Checklist to facilitate the safe reopening of surgical practices. 

The organizations issued the list for reopening ambulatory surgery centers.

A guidance issued in March limited practices to emergencies and emergent care.

For nearly two months, the nation has focused on social distancing and shelter-in-place rules in an effort to reduce the spread of COVID-19.

“We are flattening the curve. It is now time to consider the process of cautiously reopening ophthalmology care and serving the growing healthcare needs of patients who deferred needed care and are at increased risk of experiencing a negative clinical outcome,” the organizations said in a statement.

While the ophthalmic community closed routine practice nationally, the groups said practice will open locally.

The decision to reopen more normal practice will be based on local and regional conditions, on public health authorities interpreting local patterns of disease, on testing availability, on institutional policies and ultimately on individual ophthalmologists.

To support the safe reopening of care, the AAO, the ASCRS, and the OOSS, developed a checklist that details specifically how to approach and manage some of the key decisions in reopening more normal practice in the COVID-19 era.

According to the groups, with respect to COVID-19 testing, facilities should adhere to state and local guidance. The statement noted that for cases at low risk for aerosolizing bodily fluids and performed under monitored anesthesia/conscious sedation, such as cataract surgery, routine preoperative RT-PCR testing should not be mandatory.

However, this may be considered for patients with risk factors on an individual basis. The groups also offered thanks to the Ambulatory Surgery Center Association (ASCA) for its contribution to the development of the checklist.

“This virus is still with us,” the groups concluded in the statement. “We simply must use our accumulated experience and scientific information and adapt to it. We must be thoughtful and careful-for our patients, our staff and colleagues, and for ourselves and our families.”

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
Elizabeth Yeu, MD, highlights from a corneal case report for a patient undergoing the triple procedure
© 2024 MJH Life Sciences

All rights reserved.